New bladder cancer drug aims to fight tumors without harming nerves
NCT ID NCT07662863
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase II trial compares a new targeted drug, sacituzumab tirumotecan (Sac-TMT), to other antibody-drug conjugates (ADCs) in people with advanced urothelial carcinoma (bladder cancer) that has worsened after prior treatment. The main goal is to see if Sac-TMT causes less severe nerve damage while still controlling the cancer. Participants will receive either Sac-TMT or another ADC, and researchers will monitor nerve health through exams, machine tests, and patient surveys.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- sacituzumab tirumotecan (Sac-TMT)
- What this could lead to
- If successful, this could offer a treatment option for advanced bladder cancer with a lower risk of severe nerve damage, improving quality of life.
- What could go wrong
- This is a phase II trial with only 75 participants, so results may not apply broadly. The drug may still cause side effects or fail to control the cancer as well as existing treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, 200032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Bag-Like device pull bladder tumors out whole?
- Can Pre-Surgery chemotherapy outsmart aggressive bladder cancer?
- Bladder cancer: a new combo aims to avoid radical surgery
- Could a simple urine test spare bladder cancer patients from chemotherapy?
- Can a new drug rally the immune system against Hard-to-Treat cancers?
- Can One-Piece tumour removal improve bladder cancer outcomes?